|
|
|
|
Patients initially treated with pramipexole demonstrated a reduction in loss of striatal [123I]B-CIT uptake, a marker of dopamine neuron degeneration, compared with those initially treated with levodopa, during a 46-month period. These imag ing data highlight the need to further compare imaging and clinical end points of PD progression in long-term studies. |
|